Certificate of Analysis (COA) View the laboratory certificate for this product [ View COA ]

Pure Cagrilintide 10mg

R 1,378.85
Add to WishlistCompare

Cagrilintide 10mg is a research-grade synthetic peptide supplied by Pure Performance Labs as lyophilised material for controlled laboratory and scientific research. Cagrilintide is a long-acting analogue of the pancreatic hormone amylin and is investigated in metabolic and receptor research.

The 10mg presentation provides a defined quantity of research material for laboratory studies requiring a consistent research sample.

This product is supplied strictly for laboratory and scientific research purposes and is not intended for human consumption, self-administration, diagnosis, treatment, prevention or veterinary use.

Each qualifying product includes 3ml of 0.9% Benzyl Alcohol Bacteriostatic Water.

Research Overview

Cagrilintide is an acylated amylin analogue investigated in research involving amylin receptor signalling, appetite-related pathways, metabolic biology and gastrointestinal processes.

Laboratory research has examined Cagrilintide in relation to receptor activity, satiety signalling, gastric emptying and metabolic pathways. Research has also investigated Cagrilintide in combination with other metabolic research compounds, including GLP-1 receptor pathway compounds. 

Key Features

• Cagrilintide 10mg research-grade peptide
• Long-acting amylin analogue
• Lyophilised research material
• Defined 10mg presentation
• Metabolic research application
• Research interest includes amylin receptor signalling
• Suitable for controlled laboratory research
• Supplied by Pure Performance Labs
• Research use only

Dosage & Usage

REFERENCE RECONSTITUTION INFORMATION

Goal: Support appetite regulation, satiety and weight management. Schedule: Once-weekly subcutaneous administration. Dose Range: 0.6–4.5 mg weekly. Reconstitution: Add 3.0 mL bacteriostatic water to one 10 mg vial (3.33 mg/mL).

Always follow sterile preparation techniques when handling research peptides.

⚠️ DISCLAIMER: This guide is for educational purposes only and is not medical advice. For research use only.

General Preparation

• Use a new sterile syringe for each injection. • Rotate injection sites. • Administer on the same day each week. • Maintenance doses above 1.0 mL require a larger syringe than a standard 1 mL insulin syringe.

  • Add 3.0 mL bacteriostatic water slowly down the vial wall. Swirl gently until dissolved. Do not shake. Refrigerate immediately after reconstitution.

CAGRILINTIDE (10MG)- RECONSTITUTION TABLES - 3ml BAC water

Reference Handling Information

Reference information for laboratory handling of Cagrilintide 10mg.

  • Schedule: Once-weekly subcutaneous administration.
  • Dose Range: 0.6–4.5 mg weekly.

Reference Parameters (Dosing & Reconstitution Guide - 3ml BAC WATER)

WeekWeekly DoseU-100 UnitsVolumeWeeks 1–20.6 mg180.18 mLWeeks 3–41.2 mg360.36 mLWeeks 5–62.4 mg720.72 mLWeeks 7+4.5 mg1351.35 mLFor laboratory research only.

Experimental Study Period

FAQ's & Tips

What is Cagrilintide 10mg?
Cagrilintide 10mg is a research-grade long-acting amylin analogue supplied as lyophilised material for controlled laboratory and scientific research.

What is Cagrilintide studied for?
Cagrilintide is investigated in research involving amylin receptor signalling, metabolic biology, appetite-related pathways and satiety research.

What format is Cagrilintide 10mg supplied in?
The product is supplied as lyophilised research material in a defined 10mg presentation.

What is the research category for Cagrilintide 10mg?
Cagrilintide 10mg is classified under Metabolic Research.

Is Cagrilintide 10mg for human use?
No. This product is supplied strictly for laboratory and scientific research purposes and is not intended for human or veterinary use.

Where can I find batch-specific analytical information?
Refer to the applicable Certificate of Analysis and batch documentation when available.

Is Cagrilintide a GLP-1 peptide?
Cagrilintide is an amylin analogue rather than a GLP-1 analogue. Its research profile is associated with amylin receptor signalling.

Can Cagrilintide be researched alongside other metabolic compounds?
Cagrilintide has been investigated in combination research with other metabolic pathway compounds. Researchers should evaluate combination studies and published evidence independently.

Research

Cagrilintide is a long-acting, acylated analogue of the pancreatic hormone amylin investigated in laboratory research involving amylin receptor signalling, appetite-related pathways, satiety mechanisms, gastric emptying and metabolic biology. Research may examine its molecular characteristics, receptor interactions and related biochemical signalling under controlled experimental conditions.

Reviews